Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1601

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 7
Chunk 1601
---
-  
     -  
     32,767  
     -  
     -  
     32,767  
     -  
     32,767 
  
    Net
    foreign translation loss 
     -  
     -  
     -  
     -  
     -  
     -  
     (90) 
     (90) 
     -  
     (90)
  
    Net
    loss 
     -  
     -  
     -  
     -  
     -  
     (7,947,107) 
     -  
     (7,947,107) 
     (8,556) 
     (7,955,663)
  
    Balance—December
    31, 2024 
     76,480  
    $9,567,439  
     566,908  
    $57  
    $34,860,590  
    $(40,527,957) 
    $135,471  
    $4,035,600  
    $(80,594) 
    $3,955,006 

F-5

    For
    the Year Ended December 31, 2023 

    Series
    A 
    Preferred Stock  
    Common
    
    Stock(1)  
    Additional
    Paid-In  
    Accumulated  
    Accumulated
    Other Comprehensive  
    Total
    Shareholders’ Equity (Deficit) Attributable  
    Noncontrolling
    Interest on  
    Total
    
    Shareholders’ Equity 

    Shares  
    Amount  
    Shares  
    Amount  
    Capital(1)  
    Deficit  
    Income
    (Loss)  
    to
    60P  
    Shareholders  
    (Deficit) 
  
    Balance—December
    31, 2022 
     -  
    $-  
     39,768  
    $4  
    $5,164,696  
    $(28,815,148) 
    $73,708  
    $(23,576,740) 
    $(572,320) 
    $(24,149,060)